Autoimmunity, phospholipid-reacting antibodies and malaria immunity
- 16 September 2014
- journal article
- Published by SAGE Publications in Lupus
- Vol. 23 (12), 1295-1298
- https://doi.org/10.1177/0961203314546021
Abstract
Several questions regarding the production and functioning of autoantibodies (AAb) during malaria infection remain open. Here we provide an overview of studies conducted in our laboratory that shed some light on the questions of whether antiphospholipid antibodies (aPL) and other AAb associated with autoimmune diseases (AID) can recognize Plasmodia antigens and exert anti-parasite activity; and whether anti-parasite phospholipid antibodies, produced in response to malaria, can inhibit phospholipid-induced inflammatory responses and protect against the pathogenesis of severe malaria. Our work showed that sera from patients with AID containing AAb against dsDNA, ssDNA, nuclear antigens (ANA), actin, cardiolipin (aCL) and erythrocyte membrane antigens recognize plasmodial antigens and can, similarly to monoclonal AAb of several specificities including phospholipid, inhibit the growth of P. falciparum in vitro. However, we did not detect a relationship between the presence of anti-glycosylphosphatidylinositol (GPI) antibodies in the serum and asymptomatic malaria infection, although we did register a relationship between these antibodies and parasitemia levels in infected individuals. Taken together, these results indicate that autoimmune responses mediated by AAb of different specificities, including phospholipid, may have anti-plasmodial activity and protect against malaria, although it is not clear whether anti-parasite phospholipid antibodies can mediate the same effect. The potential effect of anti-parasite phospholipid antibodies in malarious patients that are prone to the development of systemic lupus erythematosus or antiphospholipid syndrome, as well as the (possibly protective?) role of the (pathogenic) aPL on the malaria symptomatology and severity in these individuals, remain open questions.This publication has 24 references indexed in Scilit:
- Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria modelVaccine, 2014
- AutoimmunityAdvances in Parasitology, 2011
- Plasmodium FalciparumPublished by Springer Science and Business Media LLC ,2003
- Synthetic GPI as a candidate anti-toxic vaccine in a model of malariaNature, 2002
- Glycosylphosphatidylinositol Anchors ofPlasmodium falciparumThe Journal of Experimental Medicine, 2000
- Autoimmunity and malaria: what are they doing together?Acta Tropica, 2000
- Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-α-inducing toxin ofPlasmodium falciparum: prospects for the immunotherapy of severe malariaPathogens and Global Health, 1993
- Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.The Journal of Experimental Medicine, 1993
- Suppression of Autoimmune Disease in NZB and (NZB×NZW)F1 Hybrid Mice by Infection with MalariaNature, 1970
- AUTOIMMUNE DISEASE AND PARASITIC INFECTIONS IN NIGERIANSThe Lancet, 1968